Evidence map›Paper›PMID 37329166›Full record

ArticleMicrobial biotechnology2023

Peptide MSI-1 inhibited MCR-1 and regulated outer membrane vesicles to combat immune evasion of Escherichia coli.

Xinyue Ye, Jian Wang, Pengfei Xu, Xiaoqian Yang, Qixue Shi, Genyan Liu, Zhaoshi Bai, Changlin Zhou, Lingman Ma

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Virulence · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xinyue YeSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Jian WangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Pengfei XuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Xiaoqian YangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Qixue ShiSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Genyan LiuDepartment of Laboratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Zhaoshi BaiJiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Changlin ZhouSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
Lingman MaSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.ORCID 0000-0002-8559-3516
China Pharmaceutical University · CNJiangsu Cancer Hospital · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymyxin resistance is conferred by MCR-1 (mobile colistin resistance 1)-induced lipopolysaccharide (LPS) modification of G

Indexed as

Escherichia coliEscherichia coli ProteinsAnti-Bacterial AgentsColistinDrug Resistance, BacterialImmune EvasionLipopolysaccharidesMicrobial Sensitivity TestsPeptidesAnti-Bacterial AgentsColistinEscherichia coli ProteinsLipopolysaccharidesMCR-1 protein, E coliPeptides

Identifiers

PMID37329166
PMCPMC10443334
OpenAlexW4381046848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.